Stay updated on Retinal Gene Therapy Clinical Trial for X-linked Retinitis Pigmentosa

Sign up to get notified when there's something new on the Retinal Gene Therapy Clinical Trial for X-linked Retinitis Pigmentosa page.
Latest website image capture
Clouds background image

Latest updates to the Retinal Gene Therapy Clinical Trial for X-linked Retinitis Pigmentosa page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the safety, tolerability, or efficacy evaluation of a single sub-retinal injection of BIIB112 in participants with X-linked retinitis pigmentosa (XLRP). This change may be significant for individuals monitoring medical and healthcare-related publications and documentation.
    Difference
    0.2%
    Check dated 2024-06-06T14:31:45.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participants, specifying that researchers are looking for individuals with a genetically confirmed diagnosis of XLRP and active disease visible within the macular region.
    Difference
    19%
    Check dated 2024-05-22T21:09:58.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    2%
    Check dated 2024-04-30T22:27:49.000Z thumbnail image

Stay in the know with updates to Retinal Gene Therapy Clinical Trial for X-linked Retinitis Pigmentosa

Enter your email address, and we'll notify you when there's something new on the Retinal Gene Therapy Clinical Trial for X-linked Retinitis Pigmentosa page.